Karyopharm Therapeutics Inc.

SEC 4 · Filed

0001193125-26-059332Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 17, 2026

Sale by Poulton Stuart

Security
Common Stock
Code
S
Shares
378
Price per share
8.63
Structured facts
{
  "code": "S",
  "date": "2026-02-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person."
  },
  "owners": [
    {
      "cik": "0001942597",
      "name": "Poulton Stuart",
      "roles": [
        "officer"
      ],
      "title": "EVP, Chief Development Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "99429",
  "price": "8.63",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "378",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}